Navigation Links
The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
Date:9/13/2007

Leading thinkers and senior executives from companies and government

organizations will gather for 3rd Annual Personalized Medicine event

produced by Burrill Life Sciences Media Group

SAN FRANCISCO, Sept. 13 /PRNewswire/ -- In the foreseeable future a trip to the doctor's office will be a radically different experience to what it is today. Armed with our complete genetic profile information about predisposition to disease, the appropriate remedial therapies, even what foods to eat will be part of the doctor's advice. While we can see the future of health care, we are still a tantalizing long way away from embracing it. There are many scientific, legal, ethical, regulatory and policy challenges that have to be addressed before personalized medicine becomes a reality in 21st century medicine.

The 3rd Burrill Personalized Medicine Meeting (San Francisco, November 12-13, 2007), hosted by Burrill Life Sciences Media Group, a joint venture of Nielsen Business Media and Burrill & Company, provides a "window" into these new realities with detailed discussions and analysis on the whole spectrum of personalized medicine -- from prediction to prevention and how they will have a major impact on the delivery of health care.

Some of the leading thinkers and senior executives from companies and government organizations will be participating in this event. Sessions include:

-- Personalized Medicine in the Clinic

-- How Science and Technology is Accelerating the Pace of Biomarker

Development

-- Targeted Treatments vs. The "one size fits all" Blockbuster

-- Pharmacogenomics comes of Age

-- The increasing role of Diagnostics in Personalized Medicine

-- Patient-centric Medicine -- Personalized Medicine from the Patient's

Point of View

-- The Regulatory Environment: The FDA's Perspective

The Burrill Personalized Medicine Meeting has established itself as a "must attend" eve
'/>"/>

SOURCE Burrill Life Sciences Media Group
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NameProtect releases annual list of top trademarkers
2. Doyle says new contracts saving state more than $16 million annually
3. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
4. Annual Bioethics Forum to explore genetic testing
5. Annual Conference Honors Tech Grant Winners
6. Winner of Burrill competition courted by North Carolina investors
7. Technology and business merge at UW Burrill Competition
8. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
9. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
10. Students Win Burrill Competition With Plan for Renewable Energy
11. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3